Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Brage Krüger-Stokke"'
Autor:
Brage Krüger-Stokke, Helena Bertilsson, Sverre Langørgen, Torill Anita Eidhammer Sjøbakk, Tone Frost Bathen, Kirsten Margrete Selnæs
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectivesThis study aims to prospectively estimate the diagnostic performance of multiparametric prostate MRI (mpMRI) and compare the detection rates of prostate cancer using cognitive targeted transrectal ultrasound (TRUS) guided biopsies, targeted
Externí odkaz:
https://doaj.org/article/33bfc7b66a4c4050ac700af508ab89e9
Autor:
Kirsten Margrete Selnæs, Brage Krüger-Stokke, Mattijs Elschot, Håkon Johansen, Per Arvid Steen, Sverre Langørgen, Bjørg Yksnøy Aksnessæther, Gunnar Indrebø, Torill Anita Eidhammer Sjøbakk, May-Britt Tessem, Siver Andreas Moestue, Heidi Knobel, Torgrim Tandstad, Helena Bertilsson, Arne Solberg, Tone Frost Bathen
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
ObjectiveSimultaneous PET/MRI combines soft-tissue contrast of MRI with high molecular sensitivity of PET in one session. The aim of this prospective study was to evaluate detection rates of recurrent prostate cancer by 18F-fluciclovine PET/MRI.Metho
Externí odkaz:
https://doaj.org/article/72abee93ba91426aa8cb05864817b5aa
Autor:
Mattijs Elschot, Håkon Johansen, Kirsten Margrete Selnæs, Helena Bertilsson, Brage Krüger-Stokke, Tone Frost Bathen
Publikováno v:
Journal of Nuclear Medicine
The objective of this study was to evaluate the effect of including bone in DIXON-based attenuation correction for 18F-fluciclovine Positron Emission Tomography (PET) / Magnetic Resonance Imaging (MRI) of primary and recurrent prostate cancer. Method
Autor:
Kirsten Margrete Selnæs, Øystein Størkersen, May-Britt Tessem, Elise Sandsmark, Brage Krüger-Stokke, Helena Bertilsson, Tone Frost Bathen, Mattijs Elschot, Siver Andreas Moestue
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose: [18F]Fluciclovine PET imaging shows promise for the assessment of prostate cancer. The purpose of this PET/MRI study is to optimise the PET imaging protocol for detection and characterisation of primary prostate cancer, by quantitative evalu
Autor:
Mattijs, Elschot, Kirsten M, Selnæs, Elise, Sandsmark, Brage, Krüger-Stokke, Øystein, Størkersen, Guro F, Giskeødegård, May-Britt, Tessem, Siver A, Moestue, Helena, Bertilsson, Tone F, Bathen
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 59(5)
The objective of this study was to investigate whether quantitative imaging features derived from combined
Autor:
Mattijs Elschot, Gabriel Nketiah, Tone Frost Bathen, Elise Sandsmark, Brage Krüger-Stokke, Kirsten Margrete Selnæs, Jose R. Teruel, Helena Bertilsson
Publikováno v:
Magnetic resonance in medicine. 79(5)
Purpose To evaluate the effect of correction for B0 inhomogeneity-induced geometric distortion in echo-planar diffusion-weighted imaging on quantitative apparent diffusion coefficient (ADC) analysis in multiparametric prostate MRI. Methods Geometric
Autor:
May-Britt Tessem, Brage Krüger-Stokke, Øystein Størkersen, Elise Sandsmark, Kirsten Margrete Selnæs, Mattijs Elschot, Guro F. Giskeødegård, Tone Frost Bathen, Siver Andreas Moestue, Helena Bertilsson
Publikováno v:
Journal of Nuclear Medicine
The objective of this study is to investigate if quantitative imaging features derived from combined 18F-Fluciclovine Positron Emission Tomograpy (PET) / multiparametric Magnetic Resonance Imaging (MRI) show potential for detection and characterizati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a60ac4ace443aaccde357eef07243147
http://hdl.handle.net/11250/2461632
http://hdl.handle.net/11250/2461632
Autor:
Mattijs, Elschot, Kirsten M, Selnæs, Elise, Sandsmark, Brage, Krüger-Stokke, Øystein, Størkersen, May-Britt, Tessem, Siver A, Moestue, Helena, Bertilsson, Tone F, Bathen
Publikováno v:
European journal of nuclear medicine and molecular imaging. 44(4)
[Patients diagnosed with high-risk primary prostate cancer underwent an integrated [Twenty-eight (28) patients [median (range) age: 66 (55-72) years] were included. An early (W1: 5-10 minutes post-injection) and two late candidate windows (W2: 18-23;